{"entity":{"id":"nct07471776","kind":"trial","name":"Study on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer","aka":[],"tldr":"A phase 2 trial of TROP2 PET in Breast cancer, run by Fudan University, now recruiting.","summary":"Study on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer is a phase 2 interventional study registered as NCT07471776 by Fudan University, with 45 participants planned, started 2026-03-11 and due to reach its primary completion in 2028-03-11. Interventions recorded: Sacituzumab Govitecan、Datopotamab deruxtecan、Sacituzumab tirumotecan, 68Ga-TROP2 PET/CT Imaging, 18F-FDG PET Imaging. Conditions recorded: Metastatic Breast Cancer ( HER2 Negative).\n\nLinked to the technology TROP2 PET because the registry names it (\"trop2 pet\") among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.","status":"recruiting","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT07471776","url":"https://clinicaltrials.gov/study/NCT07471776"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["breast-cancer"],"sections":[],"technologies":["trop2-pet"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07471776","phase":"2","setting":"Study on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer","sponsor":"Fudan University","participation":[{"nct":"NCT07471776","source":"https://clinicaltrials.gov/study/NCT07471776","fetchedAt":"2026-10-07T16:55:46.774Z","studySha256":"de6c1aa9497137794e609b927442e6563673ae3cf7f190dd002e35d0ffa7a629","overallStatus":"RECRUITING","lastUpdatePosted":"2026-03-13","leadSponsor":"Fudan University","collaboratorCount":0,"minimumAge":"18 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":45,"enrolmentType":"ESTIMATED","siteCount":2,"recruitingSiteCount":1,"countries":["China"]}],"started":"2026-03-11","startedType":"actual","enrolled":45,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07471776/","neighbours":{"cancer":[{"id":"breast-cancer","kind":"cancer","name":"Breast cancer (all types)","route":"/cancers/breast-cancer/"}],"technology":[{"id":"trop2-pet","kind":"technology","name":"TROP2 PET","route":"/technologies/trop2-pet/"}]}}